Can a phone app and fitbit ease cancer treatment? new study says maybe.
NCT ID NCT03022032
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 31 times
Summary
This study tested whether a smartphone app paired with a Fitbit could help women with recurrent, incurable gynecologic cancers manage symptoms and improve their quality of life. 102 women receiving chemotherapy used the app and Fitbit to track symptoms and get advice. The main goal was to see if patients would actually use the tools and find them helpful, not to measure health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
smartphone app (HOPE app, SMART study app, Beiwe study app) and Fitbit device (Fitbit Zip or Fitbit Charge 2)
What this could lead to
If successful, this approach could provide a simple, at-home way for women with gynecologic cancer to track symptoms and get tailored advice, potentially improving their quality of life during treatment.
What could go wrong
This is a small, early feasibility study (102 participants) focused on whether patients would use the tools, not on proving they improve health outcomes. The results may not apply to all patients or settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.